Genetically Modified Microorganism For Producing medium-chain lauric acid and/or dodecanedioic acid And Method of Using Thereof

US2017191092A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2017191092-A1
Application numberUS-201615394047-A
CountryUS
Kind codeA1
Filing dateDec 29, 2016
Priority dateJul 18, 2014
Publication dateJul 6, 2017
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein are genetically-modified microorganisms for producing medium chain lauric acid and/or dodecanedioic acid and methods of using the microorganisms. The microorganisms contain a nucleic acid encoding an Umbellularia californica lauroyl ACP-thioesterase (BTE) operably linked to a promoter.

First claim

Opening claim text (preview).

What is claimed is: 1 . A genetically modified microorganism, comprising a nucleic acid encoding an Umbellularia californica lauroyl ACP-thioesterase (BTE) operably linked to a promoter, wherein the microorganism produces an increased amount of medium-chain lauric acid and/or dodecanedioic acid as compared to the unmodified parent of the microorganism. 2 . The genetically modified microorganism of claim 1 , wherein the Umbellularia californica lauroyl ACP-thioesterase (BTE) is a modified Umbellularia californica lauroyl ACP-thioesterase (BTE). 3 . The genetically modified microorganism of claim 2 , wherein the modified Umbellularia californica lauroyl ACP-thioesterase (BTE) comprises residues 17-283 of a wild-type Umbellularia californica lauroyl ACP-thioesterase (BTE). 4 . The genetically modified microorganism of claim 3 , wherein the modified Umbellularia californica lauroyl ACP-thioesterase (BTE) further comprises a C-terminal His-tag fusion. 5 . The genetically modified microorganism of claim 2 , wherein the modified Umbellularia californica lauroyl ACP-thioesterase (BTE) comprises residues 17-295 of a wild-type Umbellularia californica lauroyl ACP-thioesterase (BTE). 6 . The genetically modified microorganism of claim 5 , wherein the modified Umbellularia californica lauroyl ACP-thioesterase (BTE) further comprises a C-terminal His-tag fusion. 7 . The genetically modified microorganism of claim 2 , wherein the modified Umbellularia californica lauroyl ACP-thioesterase (BTE) consists of residues 17-283 of a wild-type Umbellularia californica lauroyl ACP-thioesterase (BTE) and a C-terminal His-tag fusion. 8 . The genetically modified microorganism of claim 7 , wherein residue 124 of the wild-type Umbellularia californica lauroyl ACP-thioesterase (BTE), cysteine, is further replaced with threonine. 9 . The genetically modified microorganism of claim 2 , wherein the modified Umbellularia californica lauroyl ACP-thioesterase (BTE) consists of residues 17-295 of a wild-type Umbellularia californica lauroyl ACP-thioesterase (BTE) and a C-terminal His-tag fusion. 10 . The genetically modified microorganism of claim 9 , wherein residue 124 of the wild-type Umbellularia californica lauroyl ACP-thioesterase (BTE), cysteine, is further replaced with threonine. 11 . The genetically modified microorganism of claim 1 , further comprising one or more additional nucleic acids each operably linked to a promoter, each additional nucleic acid encoding a protein selected from the group consisting of an acetyl-CoA carboxylase (ACC), an acetyl-CoA carboxylase carboxyl transferase subunit α (AccA), an acetyl-CoA carboxylase biotin carboxyl carrier protein (AccB), an acetyl-CoA biotin carboxylase (AccC), an acetyl-CoA carboxylase transferase subunit β (AccD), a fatty acid synthase (FAS) subunit, a cytochrome P450 reductase (CPR), a long-chain alcohol oxidase (FAO1), a long-chain alcohol dehydrogenase (FADH), and an adenosine monophosphate-forming acetyl-coenzyme A synthetase (AceCS). 12 . The genetically modified microorganism of claim 1 , further comprising additional nucleic acids each encoding a CPR, a FAO1, and a FADH, respectively. 13 . The genetically modified microorganism of claim 1 , further comprising a loss-of-function mutation in or expressing a lower level of one or more genes selected from the group consisting of a palmitoyl-acyl carrier protein (ACP) thioesterase gene, an acyl-coenzyme A oxidase gene, a citric synthetase (gltA) gene, or an acyl-coenzyme A synthetase (acs) gene. 14 . The genetically modified microorganism of claim 1 , further comprising a loss-of-function mutation in or expressing a lower level of an acyl-coenzyme A oxidase gene. 15 . The genetically modified microorganism of claim 14 , wherein the acyl-coenzyme A oxidase gene is pox2, pox5, or fadD. 16 . The genetically modified microorganism of claim 1 , wherein the microorganism (1) contains a loss-of-function mutation in or expresses a lower level of an acyl-coenzyme A oxidase gene and (2) contains additional nucleic acids each encoding a CPR, a FAO1, and a FADH, respectively. 17 . The genetically modified microorganism of claim 2 , wherein the microorganism (1) contains a loss-of-function mutation in or expresses a lower level of an acyl-coenzyme A oxidase gene and (2) contains additional nucleic acids each encoding a CPR, a FAO1, and a FADH, respectively. 18 . The genetically modified microorganism of claim 17 , wherein the acyl-coenzyme A oxidase gene is fadD. 19 . The genetically modified microorganism of claim 1 , wherein the microorganism is Yarrowia lipolytica or Escherichia coli. 20 . A method of producing a medium-chain lauric acid and/or dodecanedioic acid, the method comprising: providing the genetically-modified microorganism of claim 1 ; and culturing the microorganism in a culture medium containing glucose or glycerol at pH 6 to 8 under conditions that allow production of the medium-chain lauric acid and/or dodecanedioic acid; whereby the microorganism produces the medium-chain lauric acid and/or dodecanedioic acid.

Assignees

Inventors

Classifications

  • Dodecanoyl-[acyl-carrier-protein] hydrolase (3.1.2.21) · CPC title

  • by hydrolysis of fatty acid esters · CPC title

  • acting on ester bonds (3.1) · CPC title

  • C12P7/6409Primary

    Fatty acids · CPC title

  • Polycarboxylic acids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2017191092A1 cover?
Described herein are genetically-modified microorganisms for producing medium chain lauric acid and/or dodecanedioic acid and methods of using the microorganisms. The microorganisms contain a nucleic acid encoding an Umbellularia californica lauroyl ACP-thioesterase (BTE) operably linked to a promoter.
Who is the assignee on this patent?
Ind Tech Res Inst
What technology area does this patent fall under?
Primary CPC classification C12P7/6409. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jul 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).